C21 Investments (XCNQ:CXXI) Buyback Yield % : 0.00 (As of May. 01, 2025)

View and export this data going back to 1987. Start your Free Trial

What is C21 Investments Buyback Yield %?

Buyback yield is the net repurchase of shares outstanding over the market capital of the company. It is a measure of shareholder return.

C21 Investments's current buyback yield was 0.00%.

C21 Investments Buyback Yield % Historical Data

The historical data trend for C21 Investments's Buyback Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

C21 Investments Buyback Yield % Chart

C21 Investments Annual Data

Trend

Jan14

Jan15

Jan16

Jan17

Jan18

Jan19

Jan20

Jan21

Jan22

Jan23

Buyback Yield %

Get a 7-Day Free Trial

-8.85

-13.45

C21 Investments Quarterly Data
	Jan20	Apr20	Jul20	Oct20	Jan21	Apr21	Jul21	Oct21	Jan22	Apr22	Jul22	Oct22	Jan23	Apr23	Jul23	Oct23	Jan24	Jun24	Sep24	Dec24
Buyback Yield %	Get a 7-Day Free Trial															1.84	1.22	-	-	-

Competitive Comparison of C21 Investments's Buyback Yield %

For the Drug Manufacturers - Specialty & Generic subindustry, C21 Investments's Buyback Yield %, along with its competitors' market caps and Buyback Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

C21 Investments's Buyback Yield % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, C21 Investments's Buyback Yield % distribution charts can be found below:

* The bar in red indicates where C21 Investments's Buyback Yield % falls into.

Save Embed

;

Save Embed

;

C21 Investments Buyback Yield % Calculation

Buyback yield is a measure of shareholder return.

C21 Investments's Buyback Yield for the fiscal year that ended in Jan. 2023 is calculated as

Buyback Yield	=	Net Issuance of Stock			/	Market Cap
	=	- (Repurchase of Stock	+	Issuance of Stock)	/	Market Cap
	=	- (0	+	0)	/	40.81632
	=	0.00%

C21 Investments's annualized Buyback Yield for the quarter that ended in Dec. 2024 is calculated as

Buyback Yield	=	Net Issuance of Stock		(TTM)		/	Market Cap
	=	- (Repurchase of Stock	+	Issuance of Stock)	(TTM)^**	/	Market Cap
	=	- (0	+	0)		/	34.81392
	=	0.00%

** If the quarter corresponds to the year-end period, we will use the annual Repurchase of Stock and Issuance of Stock data .

C21 Investments Buyback Yield % Related Terms

Thank you for viewing the detailed overview of C21 Investments's Buyback Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.

C21 Investments Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » C21 Investments Inc (XCNQ:CXXI) » Definitions » Buyback Yield %

Comparable Companies

Traded in Other Exchanges

CXXIF:USA

Address

601 West Cordova Street, Suite 170, Vancouver, BC, CAN, V6B 1G1

Website

https://www.cxxi.ca

C21 Investments Inc is a vertically integrated cannabis company that cultivates, processes, and distributes quality cannabis and hemp-derived consumer products in the United States. The Company owns Silver State Relief and Silver State Cultivation in Nevada, including legacy Oregon brands Phantom Farms, Hood Oil and Eco Firma Farms. These brands produce and distribute a broad range of THC and CBD products from cannabis flowers, pre-rolls, cannabis oil, vaporizer cartridges and edibles.

Executives

Todd Andrew Harrison	Director
Bruce Macdonald	Director
Sky Pinnick	Director
Leonard Werden	Director
Michael Starrett Kidd	Director, Senior Officer

C21 Investments Headlines

No Headlines